MMP26 and neoplasm: The present work focuses on determining the screening utility of metalloproteinases, namely, matrilysins (MMP-7 and MMP-26) and stromelysins (MMP-3 and MMP-10), as modern tumor markers in patients with EC compared to women with benign lesions (myometrium) and healthy controls in independent analyses and in correlation with the routine marker CA125.